Shih‐Cheng Yang

560 total citations
36 papers, 402 citations indexed

About

Shih‐Cheng Yang is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, Shih‐Cheng Yang has authored 36 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Gastroenterology, 19 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in Shih‐Cheng Yang's work include Gastroesophageal reflux and treatments (16 papers), Helicobacter pylori-related gastroenterology studies (14 papers) and Liver Disease Diagnosis and Treatment (12 papers). Shih‐Cheng Yang is often cited by papers focused on Gastroesophageal reflux and treatments (16 papers), Helicobacter pylori-related gastroenterology studies (14 papers) and Liver Disease Diagnosis and Treatment (12 papers). Shih‐Cheng Yang collaborates with scholars based in Taiwan, United States and Australia. Shih‐Cheng Yang's co-authors include Seng‐Kee Chuah, Wei‐Chen Tai, Chih‐Ming Liang, Cheng‐Kun Wu, Chien‐Ning Hsu, Keng‐Liang Wu, Chen‐Hsiang Lee, Yuan‐Hung Kuo, Deng‐Chyang Wu and Pin‐I Hsu and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Environmental Research and Public Health.

In The Last Decade

Shih‐Cheng Yang

34 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Cheng Yang Taiwan 12 266 121 111 105 74 36 402
Patrice A. Michaletz United States 11 516 1.9× 301 2.5× 63 0.6× 47 0.4× 166 2.2× 15 650
В. В. Цуканов Russia 10 271 1.0× 137 1.1× 116 1.0× 39 0.4× 127 1.7× 102 507
Ji‐Yuh Lee Taiwan 7 198 0.7× 108 0.9× 59 0.5× 53 0.5× 127 1.7× 14 356
Yong Cheol Jeon South Korea 13 233 0.9× 113 0.9× 99 0.9× 71 0.7× 185 2.5× 45 498
Barbara Tribl Austria 11 177 0.7× 63 0.5× 155 1.4× 143 1.4× 85 1.1× 22 395
Masao Kobayakawa Japan 12 272 1.0× 124 1.0× 80 0.7× 53 0.5× 170 2.3× 50 423
Fabio Cisarò Italy 11 256 1.0× 207 1.7× 182 1.6× 54 0.5× 72 1.0× 29 435
Sun Moon Kim South Korea 11 203 0.8× 101 0.8× 73 0.7× 27 0.3× 127 1.7× 51 378
Aniruddha Phadke India 11 167 0.6× 45 0.4× 157 1.4× 74 0.7× 39 0.5× 25 347
Simona Capodicasa Italy 8 360 1.4× 72 0.6× 67 0.6× 28 0.3× 281 3.8× 10 501

Countries citing papers authored by Shih‐Cheng Yang

Since Specialization
Citations

This map shows the geographic impact of Shih‐Cheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Cheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Cheng Yang more than expected).

Fields of papers citing papers by Shih‐Cheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Cheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Cheng Yang. The network helps show where Shih‐Cheng Yang may publish in the future.

Co-authorship network of co-authors of Shih‐Cheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Cheng Yang. A scholar is included among the top collaborators of Shih‐Cheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Cheng Yang. Shih‐Cheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tai, Wei‐Chen, Pao‐Yuan Huang, Chih‐Chien Yao, et al.. (2024). The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan. Journal of Microbiology Immunology and Infection. 57(4). 601–608. 2 indexed citations
3.
Huang, Pao‐Yuan, Shih‐Cheng Yang, Ming‐Kung Wu, et al.. (2023). Correlation between Psychosomatic Assessment, Heart Rate Variability, and Refractory GERD: A Prospective Study in Patients with Acid Reflux Esophagitis. Life. 13(9). 1862–1862. 5 indexed citations
4.
Tai, Wei‐Chen, Shih‐Cheng Yang, Lung‐Sheng Lu, et al.. (2023). The Clinical Presentations of Liver Abscess Development After Endoscopic Retrograde Cholangiopancreatography with Choledocholithiasis: A 17-Year Follow-Up. Infection and Drug Resistance. Volume 16. 6167–6174. 2 indexed citations
5.
Wu, Cheng‐Kun, Chien‐Ning Hsu, Shih‐Cheng Yang, et al.. (2021). Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis. Infection and Drug Resistance. Volume 14. 2121–2131. 4 indexed citations
6.
Yang, Shih‐Cheng, Chih‐Chien Yao, Chih‐Ming Liang, et al.. (2021). Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice. Infection and Drug Resistance. Volume 14. 1239–1246. 2 indexed citations
7.
Hsu, Chien‐Ning, Shih‐Cheng Yang, Cheng‐Kun Wu, et al.. (2020). The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients. Scientific Reports. 10(1). 21329–21329. 5 indexed citations
8.
Huang, Tzu‐Hsin, Shih‐Cheng Yang, Wei‐Chen Tai, et al.. (2020). The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance. Biomedical Journal. 44(6). S275–S281. 7 indexed citations
9.
Yao, Chih‐Chien, Chung‐Mou Kuo, Chien‐Ning Hsu, et al.. (2019). <p>First-line <em>Helicobacter pylori</em> eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus</p>. Infection and Drug Resistance. Volume 12. 1425–1431. 17 indexed citations
10.
Liang, Chih‐Ming, Shih‐Cheng Yang, Cheng‐Kun Wu, et al.. (2019). Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs. Journal of Clinical Medicine. 8(10). 1722–1722. 8 indexed citations
11.
12.
Wu, Cheng‐Kun, Shih‐Cheng Yang, Yuchi Li, et al.. (2019). The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis. Journal of Gastroenterology and Hepatology. 35(5). 777–787. 8 indexed citations
13.
Wu, Deng‐Chyang, Pin‐I Hsu, Chao‐Hung Kuo, et al.. (2019). <p>Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial</p>. Drug Design Development and Therapy. Volume 13. 1347–1356. 5 indexed citations
14.
Wu, Cheng‐Kun, Chih‐Ming Liang, Wei‐Chen Tai, et al.. (2018). Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. International Journal of Environmental Research and Public Health. 15(12). 2655–2655. 13 indexed citations
15.
Chuah, Seng‐Kee, Shih‐Cheng Yang, Chih‐Ming Liang, et al.. (2018). Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis. PLoS ONE. 13(5). e0197127–e0197127. 15 indexed citations
16.
Wang, Jiunn‐Wei, Chien‐Ning Hsu, Chih‐Ming Liang, et al.. (2018). Association between Helicobacter pylori eradication and the risk of coronary heart diseases. PLoS ONE. 13(1). e0190219–e0190219. 29 indexed citations
17.
Yang, Shih‐Cheng, Wei‐Chen Tai, Chih‐Ming Liang, et al.. (2018). Efficacy of a 14-day quadruple-therapy regimen for third-line <em>Helicobacter pylori</em> eradication. Infection and Drug Resistance. Volume 11. 2073–2080. 13 indexed citations
18.
Hung, Tsung‐Hsing, Chih‐Ming Liang, Chien‐Ning Hsu, et al.. (2017). Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan. PLoS ONE. 12(7). e0181858–e0181858. 29 indexed citations
19.
Wu, Cheng‐Kun, Chih‐Ming Liang, Chien‐Ning Hsu, et al.. (2017). The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation. PLoS ONE. 12(1). e0169884–e0169884. 6 indexed citations
20.
Wu, Cheng‐Kun, Hon‐Yi Shi, Wei‐Chen Tai, et al.. (2016). Medical expenses in treating acute esophageal variceal bleeding. Medicine. 95(28). e4215–e4215. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026